homefeedbacksupportlog on 20-Nov-2008 
  Search
 
   
 
  Browse
ALL OF BIOLOGY

Pharmacology & Drug Discovery
Immunopharmacology & Hematologic Pharmacology
Related Sections

profile subject selected for My F1000 Biology

Browse > Pharmacology & Drug Discovery > Immunopharmacology & Hematologic Pharmacology
Top 10 / All time Top 10 / Most viewed / Hidden jewels
Page 1 of 24. Select Page: 1 2 3 4 5 6 7 8 9 10 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Recommended
F1000 Factor 3.0

Hypothesis
New Finding
Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T, Lou J, …, McEver RP, Zhu C
J Clin Invest 2008 Sep 118(9):3195-207 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Xiaoping Du
Evaluated 20 Nov 2008

Recommended
F1000 Factor 3.0

New Finding
Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I IFN, and immune suppression.
Malleret B, Maneglier B, …, Le Grand R, Vaslin B
Blood 2008 Sep 11 [abstract on PubMed] [related articles] [full text]
Selected by | Gene Shearer with Adriano Boasso
Evaluated 18 Nov 2008

Must Read
F1000 Factor 6.0

New Finding
Memory CD8 T-cell compartment grows in size with immunological experience.
Vezys V, Yates A, …, Antia R, Masopust D
Nature 2008 Nov 12 [abstract on PubMed] [related articles] [full text]
Selected by | Barry Rouse
Evaluated 18 Nov 2008

Recommended
F1000 Factor 3.0

Confirmation
New Finding
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
Schneider A, Rieck M, …, Greenbaum C, Buckner JH
J Immunol 2008 Nov 15 181(10):7350-5 [abstract on PubMed] [related articles] [order article]
Selected by | Matthias von Herrath with Christophe Filippi
Evaluated 14 Nov 2008

Recommended
F1000 Factor 3.0

New Finding
Novel Drug Target
Alternate mRNA splicing in multiple human tryptase genes is predicted to regulate tetramer formation.
Jackson NE, Wang HW, …, Cairns J, Hunt JE
J Biol Chem 2008 Oct 14 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Richard L. Stevens
Evaluated 13 Nov 2008

Recommended
F1000 Factor 3.2

New Finding
Tech Advance
Novel Drug Target
Engineering microRNA responsiveness to decrease virus pathogenicity.
Kelly EJ, Hadac EM, Greiner S, Russell SJ
Nat Med 2008 Nov 14(11):1278-83 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | James Crowe / Lynne Maquat with Olaf Isken
First evaluation 12 Nov 2008 | Latest evaluation 19 Nov 2008

Must Read
F1000 Factor 6.0

New Finding
Novel Drug Target
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity.
Rubic T, Lametschwandtner G, …, Rot A, Carballido JM
Nat Immunol 2008 Nov 9(11):1261-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Mauro Teixeira
Evaluated 10 Nov 2008

Recommended
F1000 Factor 3.0

Hypothesis
Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells.
Perreau M, Pantaleo G, Kremer EJ
J Exp Med 2008 Nov 3 [abstract on PubMed] [related articles] [full text]
Selected by | Lindsey Hutt-Fletcher
Evaluated 6 Nov 2008


Recommended
F1000 Factor 3.0

New Finding
Novel Drug Target
ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury.
Noma K, Rikitake Y, …, Sun J, Liao JK
J Clin Invest 2008 May 118(5):1632-44 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Ivan McMurtry
Evaluated 3 Nov 2008

Must Read
F1000 Factor 6.0

New Finding
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice.
McKinley L, Alcorn JF, …, Ray A, Kolls JK
J Immunol 2008 Sep 15 181(6):4089-97 [abstract on PubMed] [related articles] [order article]
Selected by | Dan Conrad
Evaluated 31 Oct 2008


top of pagePage 1 of 24. Select Page: 1 2 3 4 5 6 7 8 9 10 >>
Display 10 / 20 / 50 papers per page


© 1999-2008 Biology Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info